Singapore markets close in 50 minutes
Straits Times Index
3,173.79 -13.87 (-0.44%) Nikkei
37,068.35 -1,011.35 (-2.66%) Hang Seng
16,236.98 -148.89 (-0.91%) FTSE 100
7,830.70 -46.35 (-0.59%) Bitcoin USD
65,000.05 +3,892.46 (+6.37%) CMC Crypto 200
1,327.14 +14.51 (+1.11%)
Pfizer Inc. (PFE)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 143.77B |
| Enterprise value | 201.93B |
| Trailing P/E | 68.62 |
| Forward P/E | 11.45 |
| PEG ratio (5-yr expected) | 0.25 |
| Price/sales (ttm) | 2.45 |
| Price/book (mrq) | 1.62 |
| Enterprise value/revenue | 3.45 |
| Enterprise value/EBITDA | 21.13 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.57 |
| 52-week change 3 | -36.86% |
| S&P500 52-week change 3 | 21.23% |
| 52-week high 3 | 40.37 |
| 52-week low 3 | 25.23 |
| 50-day moving average 3 | 27.14 |
| 200-day moving average 3 | 30.79 |
Share statistics
| Avg vol (3-month) 3 | 42.9M |
| Avg vol (10-day) 3 | 37.39M |
| Shares outstanding 5 | 5.66B |
| Implied shares outstanding 6 | 5.72B |
| Float 8 | 5.64B |
| % held by insiders 1 | 0.05% |
| % held by institutions 1 | 69.95% |
| Shares short (28 Mar 2024) 4 | 65M |
| Short ratio (28 Mar 2024) 4 | 1.4 |
| Short % of float (28 Mar 2024) 4 | 1.15% |
| Short % of shares outstanding (28 Mar 2024) 4 | 1.15% |
| Shares short (prior month 29 Feb 2024) 4 | 66.12M |
Dividends & splits
| Forward annual dividend rate 4 | 1.68 |
| Forward annual dividend yield 4 | 6.62% |
| Trailing annual dividend rate 3 | 1.64 |
| Trailing annual dividend yield 3 | 6.45% |
| 5-year average dividend yield 4 | 3.97 |
| Payout ratio 4 | 443.24% |
| Dividend date 3 | 01 Mar 2024 |
| Ex-dividend date 4 | 25 Jan 2024 |
| Last split factor 2 | 1054:1000 |
| Last split date 3 | 17 Nov 2020 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 3.62% |
| Operating margin (ttm) | -49.97% |
Management effectiveness
| Return on assets (ttm) | 1.55% |
| Return on equity (ttm) | 2.35% |
Income statement
| Revenue (ttm) | 58.5B |
| Revenue per share (ttm) | 10.37 |
| Quarterly revenue growth (yoy) | -41.30% |
| Gross profit (ttm) | N/A |
| EBITDA | 11.52B |
| Net income avi to common (ttm) | 2.13B |
| Diluted EPS (ttm) | 0.37 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 12.69B |
| Total cash per share (mrq) | 2.25 |
| Total debt (mrq) | 75.33B |
| Total debt/equity (mrq) | 84.37% |
| Current ratio (mrq) | 0.91 |
| Book value per share (mrq) | 15.77 |
Cash flow statement
| Operating cash flow (ttm) | 8.7B |
| Levered free cash flow (ttm) | 1.02B |
© 2024 Yahoo. All rights reserved.